You are here

diabetes

Tandem warns iPhone app still draining insulin pump batteries

Medtech Dive

Thu, 08/15/24 - 10:27 pm

Tandem Diabetes

Abbott’s FreeStyle Libre CGM Meets Medtronic’s Insulin Delivery

Xtalks

Tue, 08/13/24 - 11:11 pm

Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech

Medical Devices and Diagnostics Industry

Mon, 08/12/24 - 05:54 pm

continuous glucose monitoring

Patients push back against Novo Nordisk move to scrap an insulin product

Reuters

Tue, 07/30/24 - 06:37 pm

long-acting insulin

As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them

Stat

Wed, 07/17/24 - 11:39 am

Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market

Reuters

Sun, 07/14/24 - 10:17 pm

Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts

Fierce Pharma

Fri, 07/12/24 - 11:33 am

FTC poised to sue drug middlemen over insulin prices

Axios

Fri, 07/12/24 - 11:30 am

Express Scripts

Ozempic's popularity leads to shortages for people with Type 2 diabetes

NPR

Wed, 07/10/24 - 11:01 am

Biden joins Sanders' campaign targeting Novo Nordisk, Eli Lilly's diabetes and obesity drug prices

Fierce Pharma

Tue, 07/2/24 - 11:46 am

Here's How Abbott Is Leaning Heavy into the Biowearables Space

Medical Devices and Diagnostics Industry

Tue, 06/11/24 - 11:16 am

Eli Lilly exec says seeing out of pocket payments for obesity drug in US

Reuters

Mon, 06/10/24 - 06:06 pm

Diabetes biotech stock Biomea tanks as FDA imposes full clinical hold

Fierce Biotech

Fri, 06/7/24 - 11:22 am

clinical trials

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Fierce Pharma

Tue, 06/4/24 - 11:38 am

type 2 diabetes

Abbott’s OTC glucose monitor ‘will grow the market’

Pharmaphorum

Tue, 06/4/24 - 11:30 am

Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial

Reuters

Fri, 05/24/24 - 11:30 am

type 2 diabetes

FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin

Reuters

Wed, 05/22/24 - 11:35 am

Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins

CNBC

Tue, 05/21/24 - 07:11 pm

GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData

BioSpace

Mon, 05/20/24 - 06:02 pm

As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters

BioSpace

Wed, 05/15/24 - 11:22 am

Pages